BACE1 and early-onset autosomal dominant Alzheimer disease: Beta-site amyloid precursor protein cleaving enzyme (BACE-1), also known as β-secretase involved in Alzheimer’s pathogenesis, is a less explored target by the medicinal chemist for treating Alzheimer’s disease.